XML 102 R92.htm IDEA: XBRL DOCUMENT v3.25.2
Equity - Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Basic        
Net income attributable to common stockholders $ 23,952 $ 47,397 $ 54,389 $ 105,270
Net income attributable to common stockholders and noncontrolling interest $ 23,952 $ 47,397 $ 54,389 $ 105,270
Weighted average shares outstanding (in shares) 192,236,206 188,655,801 191,154,501 188,683,095
Weighted average shares outstanding (in shares) 192,236,206 188,655,801 191,154,501 188,683,095
Net income per common share (in dollars per share) $ 0.12 $ 0.25 $ 0.28 $ 0.56
Diluted        
Net income attributable to common stockholders $ 23,952 $ 47,397 $ 54,389 $ 105,270
Net income attributable to noncontrolling interest 2,015 4,094 4,617 9,090
Interest expense on convertible notes 0 0 0 0
Net income attributable to common stockholders and noncontrolling interest $ 25,967 $ 51,491 $ 59,006 $ 114,360
Weighted average shares outstanding (in shares) 192,236,206 188,655,801 191,154,501 188,683,095
Dilutive effect of OP Units (in shares) 16,173,761 16,293,589 16,211,314 16,293,589
Dilutive effect of convertible notes (in shares) 0 0 0 0
Dilutive effect of RSUs (in shares) 593,035 538,321 572,759 522,935
Weighted average shares outstanding (in shares) 209,003,002 205,487,711 207,938,574 205,499,619
Net income per common share (in dollars per share) $ 0.12 $ 0.25 $ 0.28 $ 0.56
Interest expense $ 6,100   $ 12,200  
Convertible senior unsecured notes        
Diluted        
Anti-dilutive shares (in shares) 17,471,534   17,543,663  
Mr. Ivan Kaufman | Performance-based restricted stock        
Diluted        
Vesting period (in years)     4 years